Most people report that their hair tends to thin and may come out more frequently in the hairbrush, rather than leaving a bald spot
Recent employer surveys show: 19% of employers with 200+ employees cover GLP-1s for weight loss 43% of employers with 5,000+ employees provide coverage 64% of employers with 20,000+ employees offer coverage Large employers are increasingly viewing obesity as a chronic condition requiring long-term treatment strategies rather than short-term interventions
Existing biomarkers mainly reflect systemic iron metabolism or oxidative stress, and have limited information on kidney-specific ferroptotic events (Wu et al., 2023)
The US Food and Drug Administration (FDA) recently removed Eli Lillys GLP-1 tirzepatide drugs Mounjaro and Zepbound from its drug shortages list, prompting a lawsuit from compounders
Each cycle of warming and cooling can accelerate degradation, even for unopened vials
Through their comprehensive medical weight loss program, patients undergo thorough metabolic testing and analysis to understand exactly how their body burns fuel